课题基金 / 基金详情

Cellular and Molecular Requirements for Medulloblastoma Tumorigenesis

Cellular and Molecular Requirements for Medulloblastoma Tumorigenesis
髓母细胞瘤肿瘤发生的细胞和分子要求
批准号:
8060761
负责人:
Desmond A Brown
金额:
$4.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2013-11-30

项目摘要

项目成果

Desmond A Brown的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):髓母细胞瘤(MB)是一种小脑神经上皮性肿瘤,是儿童最常见的中枢神经系统(CNS)恶性肿瘤。虽然存活率在过去20年中显著提高,但大约三分之一的人仍然无法接受治疗,目前的治疗方案会导致长期的破坏性后遗症。像其他几种肿瘤一样,MBS被认为来自一种具有干细胞样特征的细胞,即所谓的癌症干细胞(CSCs)。在中枢神经系统的几个肿瘤中已经发现了干细胞样癌细胞。然而,目前尚不清楚肿瘤是否源自这些细胞,只是被肿瘤基质释放的趋化因子招募到部位,或者肿瘤内的细胞是否去分化为这些干细胞样细胞。肿瘤起源于干细胞样细胞的可能性对治疗具有重要意义,因为大多数抗肿瘤方案旨在消除高增殖指数的细胞,这不是某些特定类别的前体细胞的特征,如B型Nestin+前体细胞。在这项研究中,MB的细胞起源将通过有条件地消融Nestin+前体细胞在疾病的小鼠模型中进行评估。我们还将评估Ccrk在小鼠神经发育中的作用,以及BROMI和CCRK在人促结缔组织MB细胞增殖和致瘤潜力中的作用。我们的研究小组最近发现,Bromi影响纤毛形态和Shh信号,并与Ccrk相关并稳定Ccrk。这项工作将促进我们对一种重要的中枢神经系统肿瘤的发病机制的理解,并最终可能促进新的诊断、预后和治疗工具的开发,并使我们能够更深入地了解普遍存在的Shh信号通路的机制细节。此外,由于Shh失调发生在所有人类肿瘤的四分之一,MB发病机制的某些方面可能适用于其他中枢神经系统肿瘤,这项研究的结果可能具有深远的影响。 公共卫生相关性:髓母细胞瘤是最常见的儿童脑部恶性肿瘤,其长期存活率很低,幸存者会有毁灭性的后遗症。该项目将解决疾病发展和维持所需的细胞来源和分子要求。这项工作的结果将加深我们对髓母细胞瘤,潜在的其他中枢神经系统肿瘤的理解,并可能揭示新的诊断、预后和治疗手段。
英文摘要
DESCRIPTION (provided by applicant): Medulloblastoma (MB) is a neuroepithelial tumor of the cerebellum and is the most common central nervous system (CNS) malignancy in children. While survival improved dramatically over the past two decades, approximately one-third remain refractory to treatment and current regimens result in long-term devastating sequelae. MBs, like several other tumors, are thought to be derived from a cell with stem-like features, so-called cancer stem cells (CSCs). Stem-like cancer cells have been demonstrated within several tumors of the CNS. However, it is unclear whether the tumors are derived from these cells, are simply recruited to the site by chemotactic factors released by the tumor stroma or whether cells within the tumor mass de-differentiate into these stem-like cells. The possibility that tumors are derived from stem-like populations has major implications for therapy since most anti- tumor regimens are geared towards elimination of cells with high proliferative index, which is not a feature of some particular classes of precursor cells such as the type B nestin+ precursor cells. In this study the cellular origins of MB will be evaluated through conditional ablation of nestin+ precursor cells in a mouse model of the disease. We will also evaluate the role of Ccrk in mouse neural development and the roles of BROMI and CCRK in the proliferation and tumorigenic potential of human desmoplastic MB cells. Our group recently showed that Bromi affects cilia morphology and Shh signaling and that it associates with and stabilizes Ccrk. This work will advance our understanding of the pathogenic mechanism of an important CNS tumor and may ultimately facilitate development of novel diagnostic, prognostic and therapeutic tools as well as enable deeper insight into the mechanistic details of the ubiquitous Shh signaling pathway. Moreover, since Shh misregulation occurs in a quarter of all human tumors and some aspects of MB pathogenesis may be generalizable to other CNS neoplasms, the results from this study may have far-reaching implications. PUBLIC HEALTH RELEVANCE: Medulloblastoma is the most common pediatric brain malignancy with dismal long-term survival and devastating sequelae in survivors. This project will address both cellular origins and molecular requirements for the development and maintenance of the disease. Results garnered from this work will deepen our understanding of medulloblastoma, potentially other CNS tumors and may reveal novel diagnostic, prognostic and therapeutic tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and Molecular Requirements for Medulloblastoma Tumorigenesis
  • 批准号:
    8194830
  • 项目类别:
  • 资助金额:
    $1.93万
  • 财政年份:
    2010
  • 负责人:
    Desmond A Brown
  • 依托单位:
国内基金
海外基金
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
  • 批准号:
    81300605
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2013
  • 负责人:
    唐琳
  • 依托单位:
Molecular Plant
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
Molecular Plant